Cardiology
Restoring R. gnavus or supplementing isovaleric acid could be a promising microbiota–based strategy to prevent or treat atrial fibrillation.
Francesco Asnicar, University of Trento (Italy), explores the role of the human gut microbiome in cardiometabolic health and diet, focusing on microbial species linked to metabolic and dietary markers.
Computer models combining oral bacteria, their metabolic functions, and saliva chemicals could better distinguish obese from healthy individuals compared with clinical measurements alone.
Gut microbes could be a target for preventing kidney disease-related heart failure.
Targeting specific gut bacteria and their metabolites could offer new ways to prevent or treat cardiovascular disease linked to diet and gut health.
Nicola Segata, from University of Trento, investigates the intricate links between diet, microbiome composition, and cardiometabolic outcomes.
The findings of a recent study shed light on how the microbiota impacts cholesterol levels. They may also inform microbial-based interventions against high cholesterol.
The findings of a recent study suggest that 2MBC exacerbates the susceptibility to thrombosis and may explain why people with COVID-19 are at increased thrombotic risk.
The findings show that statin-induced high blood sugar levels are associated with Clostridium bacteria and bile acids. The work also suggests that ursodiol may help reduce the adverse effects of…
A recent study poses the basis for the use of microbiome profile in AF risk prediction.
